home / stock / ipci / ipci quote
Last: | $ |
---|---|
Change Percent: | -22.00% |
Open: | $0.22 |
Close: | $0.2106 |
High: | $0.267 |
Low: | $0.21 |
Volume: | 2,279,585 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.22 | $0.2106 | $0.267 | $0.21 | 2,279,585 | 03-20-2019 |
$ | $0.275 | $0.27 | $0.2786 | $0.2619 | 127,424 | 03-19-2019 |
$ | $0.27 | $0.275 | $0.2822 | $0.25 | 343,757 | 03-18-2019 |
$ | $0.25 | $0.2531 | $0.27 | $0.25 | 332,663 | 03-15-2019 |
$ | $0.2525 | $0.263 | $0.2755 | $0.245 | 204,353 | 03-14-2019 |
$ | $0.23 | $0.254 | $0.265 | $0.23 | 385,400 | 03-13-2019 |
$ | $0.2774 | $0.2448 | $0.2774 | $0.2404 | 201,082 | 03-12-2019 |
$ | $0.248 | $0.24 | $0.249 | $0.24 | 105,582 | 03-11-2019 |
$ | $0.233 | $0.2422 | $0.2488 | $0.2203 | 544,714 | 03-08-2019 |
$ | $0.26 | $0.245 | $0.2682 | $0.21 | 810,812 | 03-07-2019 |
$ | $0.2699 | $0.2505 | $0.27 | $0.25 | 594,899 | 03-06-2019 |
$ | $0.29 | $0.2735 | $0.29 | $0.2668 | 556,611 | 03-05-2019 |
$ | $0.3199 | $0.29 | $0.3445 | $0.2803 | 1,800,992 | 03-04-2019 |
$ | $0.2999 | $0.2751 | $0.30 | $0.26 | 1,942,164 | 03-01-2019 |
$ | $0.321 | $0.3119 | $0.33 | $0.3105 | 693,438 | 02-28-2019 |
$ | $0.3352 | $0.3245 | $0.3416 | $0.3201 | 683,090 | 02-27-2019 |
$ | $0.3499 | $0.3401 | $0.3582 | $0.31 | 3,055,414 | 02-26-2019 |
$ | $0.357 | $0.3435 | $0.3699 | $0.34 | 1,116,195 | 02-25-2019 |
$ | $0.39 | $0.38 | $0.39 | $0.3601 | 1,423,679 | 02-22-2019 |
$ | $0.3799 | $0.3867 | $0.40 | $0.344253 | 2,884,772 | 02-21-2019 |
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc. Company Name:
IPCI Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / March 19, 2019 / Intellipharmaceutics International Inc. (Nasdaq and TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
TORONTO, ON / ACCESSWIRE / March 4, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rele...
TORONTO, ON / ACCESSWIRE / February 22, 2019 / Intellipharmaceutics International Inc. (NASDAQ: IPCI, TSX: IPCI) (''Intellipharmaceutics'' or the ''Company''), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targe...